LHC Group Inc. Announces Review of Strategic Alternatives

LAFAYETTE, La., Feb. 14, 2012 (GLOBE NEWSWIRE) — LHC Group Inc. (Nasdaq:LHCG), a national provider of post-acute care services, announced today that its Board of Directors and management are engaged in a process to review strategic alternatives.

This review process involves an exploration and evaluation of a range of strategic alternatives to enhance stockholder value. The Board of Directors and management, working with advisers, plan to proceed in a timely and orderly manner, but have not set a definitive timetable for completion of this process.

There can be no assurance that this review process will result in a transaction or strategic alternative of any kind or of the potential timing or terms of any such transaction or strategic alternative. The Company does not intend to disclose developments or provide updates on the progress or status of this process unless it deems further disclosure is appropriate or required.

The Company has retained J.P. Morgan Securities, LLC, as its financial adviser and Alston & Bird, LLP, as its legal counsel to assist in this review process.

About LHC Group Inc.

LHC Group Inc. is a national provider of home health and hospice services, providing quality, cost-effective health care to patients within the comfort and privacy of their home or place of residence. LHC Group provides a comprehensive array of post-acute healthcare services through home health, hospice and private duty locations in its home-based division and long-term acute care hospitals in its facility-based division.

Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements about the Company’s future financial performance and the strength of the Company’s operations. Such forward-looking statements may be identified by words such as “continue,” “expect,” and similar expressions. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including changes in reimbursement, changes in government regulations, changes in LHC Group’s relationships with referral sources, increased competition for LHC Group’s services, increased competition for joint venture and acquisition candidates, changes in the interpretation of government regulations, and other risks set forth in Item 1A. Risk Factors in LHC Group’s Annual Report on Form 10-K for the year ended December 31, 2010, filed with the Securities and Exchange Commission. LHC Group undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT:
Eric Elliott Investor Relations
(337) 233-1307
eric.elliott@lhcgroup.com

In The News

LHC Group Disclaimer

As part of our commitment to you, we have partnered with Krames Online to provide this resource for informational and educational purposes only. Medical information provided by this separate site or any other Web site should not be considered professional medical analysis or advice and should not be used for any recommendations on treatment.

All information provided by Krames Online is what we consider to be current, correct and in your best interest. However, medical information constantly changes with new developments and research and we cannot assure you that the information will be current when you access it. Krames Online is solely responsible for the accuracy of their content.

You should always consult your physician or other healthcare professionals for specific advice regarding any medical or health condition.

You are now leaving the LHC Group Web site and will be directed to Krames Online. A separate window will appear seconds after pressing Continue – the LHC Group Web site will remain intact and ready for use upon your return.